Primaquine

Primaquine (CAS No.: 90-34-6) is an 8-aminoquinoline derivative widely used as a reference antimalarial compound in biomedical research, characterized by potent activity against hepatic stages and sexual forms of Plasmodium species. It functions as a gametocytocidal agent in Plasmodium falciparum and is particularly noted for its ability to eliminate liver-stage schizonts and dormant hypnozoites of Plasmodium vivax and Plasmodium ovale, thereby serving as a key tool for studying parasite relapse biology. Although its precise molecular mechanism remains incompletely defined, evidence suggests that primaquine interferes with parasite mitochondrial function and nucleic acid processes, contributing to oxidative stress and disruption of essential cellular pathways. In vitro studies demonstrate activity in the nanomolar to micromolar range depending on parasite stage and assay conditions. Primaquine is frequently employed in cell-based assays and animal models to investigate antiplasmodial efficacy, transmission-blocking activity, and toxicity profiles, with experimental concentrations or dosing regimens tailored to specific study designs. Due to its known capacity to induce oxidative damage in erythrocytes under certain conditions, it is also utilized in mechanistic studies exploring redox biology and host susceptibility factors such as glucose-6-phosphate dehydrogenase deficiency.